comp_molregno,act_standard_units,act_standard_type,act_activity_comment,act_bao_endpoint,act_type,ass_assay_id,ass_description,ass_assay_type,ass_assay_category,ass_chembl_id,doc_doi,doc_pubmed_id,doc_chembl_id,doc_title,doc_doc_type,doc_abstract,doc_patent_id,coms_canonical_smiles,comp_full_molformula,mold_chembl_id,act_0
AUSCDMYCFSINPV-UHFFFAOYSA-N,%,% Inhibition of Control Specific Binding (Mean n=2),,BAO_0000179,% Inhibition of Control Specific Binding (Mean n=2),AGONIST,115319,AR (h) Eurofins-Cerep binding assay,In vitro,,,,10.6019/CHEMBL4507311,CHEMBL4507311,Data for DCP probe A-1155463,SGC Frankfurt,"SGC Frankfurt donated chemical probe project: A-1155463 was donated by Abbvie. Website: https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/A-1155463. Control: A-1107969. References: 1. Tao, Zhi-Fu, Lisa Hasvold, Le Wang, Xilu Wang, Andrew M Petros, Chang H Park, Erwin R Boghaert, Nathaniel D Catron, Jun Chen, Peter M Colman, Peter E Czabotar, Kurt Deshayes, Wayne J Fairbrother, John A Flygare, Sarah G Hymowitz, Sha Jin, Russell A Judge, Michael F T Koehler, Peter J Kovar, Guillaume Lessene, Michael J Mitten, Chudi O Ndubaku, Paul Nimmer, Hans E Purkey, Anatol Oleksijew, Darren C Phillips, Brad E Sleebs, Brian J Smith, Morey L Smith, Stephen K Tahir, Keith G Watson, Yu Xiao, John Xue, Haichao Zhang, Kerry Zobel, Saul H Rosenberg, Chris Tse, Joel D Leverson, Steven W Elmore, and Andrew J Souers. 2014. ‘Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity’. ACS Medicinal Chemistry Letters 5(10):1088–93. PMID: 25313317. 2. Leverson, Joel D, Darren C Phillips, Michael J Mitten, Erwin R Boghaert, Dolores Diaz, Stephen K Tahir, Lisa D Belmont, Paul Nimmer, Yu Xiao, Xiaoju Max Ma, Kym N Lowes, Peter Kovar, Jun Chen, Sha Jin, Morey Smith, John Xue, Haichao Zhang, Anatol Oleksijew, Terrance J Magoc, Kedar S Vaidya, Daniel H Albert, Jacqueline M Tarrant, Nghi La, Le Wang, Zhi-Fu Tao, Michael D Wendt, Deepak Sampath, Saul H Rosenberg, Chris Tse, David C S Huang, Wayne J Fairbrother, Steven W Elmore, and Andrew J Souers. 2015. ‘Exploiting Selective BCL-2 Family Inhibitors to Dissect Cell Survival Dependencies and Define Improved Strategies for Cancer Therapy’. Science Translational Medicine 7(279):279ra40. PMID: 25787766. 3. Bulanova, Daria, Aleksandr Ianevski, Andrii Bugai, Yevhen Akimov, Suvi Kuivanen, Henrik Paavilainen, Laura Kakkola, Jatin Nandania, Laura Turunen, Tiina Ohman, Hanna Ala-Hongisto, Hanna M Pesonen, Marika S Kuisma, Anni Honkimaa, Emma L Walton, Valentyn Oksenych, Martina B Lorey, Dmitry Guschin, Jungmin Shim, Jinhee Kim, Thoa T Than, So Young Chang, Veijo Hukkanen, Evgeny Kulesskiy, Varpu S Marjomaki, Ilkka Julkunen, Tuula A Nyman, Sampsa Matikainen, Jani S Saarela, Famara Sane, Didier Hober, Gülsah Gabriel, Jef K De Brabander, Miika Martikainen, Marc P Windisch, Ji-Young Min, Roberto Bruzzone, Tero Aittokallio, Markus Vähä-Koskela, Olli Vapalahti, Arto Pulk, Vidya Velagapudi, and Denis E Kainov. 2017. ‘Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins’. Viruses 9(10). PMID: 28946654.","InChI=1S/C34H26N8O4S2/c43-31(40-33-38-26-6-1-2-7-27(26)47-33)24-5-3-4-20-12-14-41(18-25(20)24)34-39-29(32(44)45)28(48-34)13-15-46-23-10-8-22(9-11-23)42-30-21(17-37-42)16-35-19-36-30/h1-11,16-17,19H,12-15,18H2,(H,44,45)(H,38,40,43)",0.19,-1.66,-12.1
CSBKUBOVPUXFLO-MAVVKCOWSA-N,%,% Inhibition of Control Specific Binding (Mean n=2),,BAO_0000179,% Inhibition of Control Specific Binding (Mean n=2),AGONIST,115318,AR (h) Eurofins-Cerep binding assay,In vitro,,,,10.6019/CHEMBL4507310,CHEMBL4507310,Data for DCP probe A-1211212,SGC Frankfurt,"SGC Frankfurt donated chemical probe project: A-1211212 was donated by Abbvie. Website: https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/A-1211212. Control: A-1210227. References: 1. Leverson, Joel D, Darren C Phillips, Michael J Mitten, Erwin R Boghaert, Dolores Diaz, Stephen K Tahir, Lisa D Belmont, Paul Nimmer, Yu Xiao, Xiaoju Max Ma, Kym N Lowes, Peter Kovar, Jun Chen, Sha Jin, Morey Smith, John Xue, Haichao Zhang, Anatol Oleksijew, Terrance J Magoc, Kedar S Vaidya, Daniel H Albert, Jacqueline M Tarrant, Nghi La, Le Wang, Zhi-Fu Tao, Michael D Wendt, Deepak Sampath, Saul H Rosenberg, Chris Tse, David C S Huang, Wayne J Fairbrother, Steven W Elmore, and Andrew J Souers. 2015. ‘Exploiting Selective BCL-2 Family Inhibitors to Dissect Cell Survival Dependencies and Define Improved Strategies for Cancer Therapy’. Science Translational Medicine 7(279):279ra40. PMID: 25787766 (Secondary paper). 2. Weder, B., M. Mozaffari, L. Biedermann, C. Mamie, A. Moncsek, L. Wang, S. H. Clarke, G. Rogler, B. L. McRae, C. L. Graff, P. A. Ruiz, and M. Hausmann. 2018. ‘BCL-2 Levels Do Not Predict Azathioprine Treatment Response in Inflammatory Bowel Disease, but Inhibition Induces Lymphocyte Apoptosis and Ameliorates Colitis in Mice’. Clinical and Experimental Immunology 193(3):346–60. PMID: 29745420 (Secondary paper).","InChI=1S/C47H54ClN7O7S/c1-47(2)18-16-34(41(27-47)32-6-8-35(48)9-7-32)30-53-20-22-54(23-21-53)36-10-14-40(44(25-36)62-38-24-33-17-19-49-45(33)51-29-38)46(56)52-63(59,60)39-13-15-42(43(26-39)55(57)58)50-28-31-4-11-37(61-3)12-5-31/h6-10,13-15,17,19,24-26,29,31,37,50H,4-5,11-12,16,18,20-23,27-28,30H2,1-3H3,(H,49,51)(H,52,56)/t31-,37-",0.07,-0.94,-8.6
KDOQEEMQPHIANX-NFBKMPQASA-N,%,% Inhibition of Control Specific Binding (Mean n=2),,BAO_0000179,% Inhibition of Control Specific Binding (Mean n=2),AGONIST,115270,AR (h) Eurofins-Cerep binding assay,In vitro,,,,10.6019/CHEMBL4507262,CHEMBL4507262,Data for DCP probe A-1596586,SGC Frankfurt,"SGC Frankfurt donated chemical probe project: A-1596586 was donated by Abbvie. Website: https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/A-1596586. Control: A-1596584. References: 1. Wang, Xueqing, Bo Liu, Xenia Searle, Clinton Yeung, Andrew Bogdan, Stephen Greszler, Ashvani Singh, Yihong Fan, Andrew M Swensen, Timothy Vortherms, Corina Balut, Ying Jia, Kelly Desino, Wenqing Gao, Hong Yong, Chris Tse, and Philip Kym. 2018. ‘Discovery of 4-[(2R,4R)-4-({[1-(2,2-Difluoro-1,3-Benzodioxol-5-Yl)Cyclopropyl]Carbonyl}amino)-7-(Difluoromethoxy)-3,4-Dihydro-2H-Chromen-2-Yl]Benzoic Acid (ABBV/GLPG-2222), a Potent Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Corrector for the Treatment of Cystic Fibrosis’. Journal of Medicinal Chemistry 61(4):1436–49. PMID: 29251932 (Probe: Cmp.13, control: Cmp. 12).","InChI=1S/C29H27F2NO7/c1-34-18-6-7-19-20(15-23(37-24(19)14-18)16-4-8-21(35-2)25(12-16)36-3)32-27(33)28(10-11-28)17-5-9-22-26(13-17)39-29(30,31)38-22/h4-9,12-14,20,23H,10-11,15H2,1-3H3,(H,32,33)/t20-,23-/m1/s1",0.43,-0.17,7.1
KDOQEEMQPHIANX-REWPJTCUSA-N,%,% Inhibition of Control Specific Binding (Mean n=2),,BAO_0000179,% Inhibition of Control Specific Binding (Mean n=2),AGONIST,115270,AR (h) Eurofins-Cerep binding assay,In vitro,,,,10.6019/CHEMBL4507262,CHEMBL4507262,Data for DCP probe A-1596586,SGC Frankfurt,"SGC Frankfurt donated chemical probe project: A-1596586 was donated by Abbvie. Website: https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/A-1596586. Control: A-1596584. References: 1. Wang, Xueqing, Bo Liu, Xenia Searle, Clinton Yeung, Andrew Bogdan, Stephen Greszler, Ashvani Singh, Yihong Fan, Andrew M Swensen, Timothy Vortherms, Corina Balut, Ying Jia, Kelly Desino, Wenqing Gao, Hong Yong, Chris Tse, and Philip Kym. 2018. ‘Discovery of 4-[(2R,4R)-4-({[1-(2,2-Difluoro-1,3-Benzodioxol-5-Yl)Cyclopropyl]Carbonyl}amino)-7-(Difluoromethoxy)-3,4-Dihydro-2H-Chromen-2-Yl]Benzoic Acid (ABBV/GLPG-2222), a Potent Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Corrector for the Treatment of Cystic Fibrosis’. Journal of Medicinal Chemistry 61(4):1436–49. PMID: 29251932 (Probe: Cmp.13, control: Cmp. 12).","InChI=1S/C29H27F2NO7/c1-34-18-6-7-19-20(15-23(37-24(19)14-18)16-4-8-21(35-2)25(12-16)36-3)32-27(33)28(10-11-28)17-5-9-22-26(13-17)39-29(30,31)38-22/h4-9,12-14,20,23H,10-11,15H2,1-3H3,(H,32,33)/t20-,23-/m0/s1",0.43,-0.17,-3.6
LQEHCKYYIXQEBM-FUKIBTTHSA-N,%,% Inhibition of Control Specific Binding (Mean n=2),,BAO_0000179,% Inhibition of Control Specific Binding (Mean n=2),AGONIST,115269,AR (h) Eurofins-Cerep binding assay,In vitro,,,,10.6019/CHEMBL4507261,CHEMBL4507261,Data for DCP probe A-192621,SGC Frankfurt,"SGC Frankfurt donated chemical probe project: A-192621 was donated by Abbvie. Website: https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/A-192621. Control: A-1806262. References: 1. Wu-Wong, J Ruth, Douglas B Dixon, William J Chiou, Brian K Sorensen, Gang Liu, H S Jae, Andrew Tasker, Thomas W von Geldern, Martin Winn, and Terry J Opgenorth. 2002. ‘Pharmacology of Endothelin Receptor Antagonists ABT-627, ABT-546, A-182086 and A-192621: In Vitro Studies’. Clinical Science (London, England: 1979) 103 Suppl 48:107S-111S. PMID: 12193066. 2. Wessale, Jerry L, Andrew L Adler, Eugene I Novosad, Samuel V Calzadilla, Brian D Dayton, Kennan C Marsh, Martin Winn, Hwan-Soo Jae, Thomas W von Geldern, Terry J Opgenorth, and J Ruth Wu-Wong. 2002. ‘Pharmacology of Endothelin Receptor Antagonists ABT-627, ABT-546, A-182086 and A-192621: Ex Vivo and in Vivo Studies’. Clinical Science (London, England: 1979) 103 Suppl 48:112S-117S. PMID: 12193067 .","InChI=1S/C33H38N2O6/c1-4-16-39-25-13-10-23(11-14-25)32-30(33(37)38)26(24-12-15-27-28(17-24)41-20-40-27)18-35(32)19-29(36)34-31-21(5-2)8-7-9-22(31)6-3/h7-15,17,26,30,32H,4-6,16,18-20H2,1-3H3,(H,34,36)(H,37,38)/t26-,30-,32+/m1/s1",0.31,-0.57,-11.6
LQEHCKYYIXQEBM-WXALXNGTSA-N,%,% Inhibition of Control Specific Binding (Mean n=2),,BAO_0000179,% Inhibition of Control Specific Binding (Mean n=2),AGONIST,115269,AR (h) Eurofins-Cerep binding assay,In vitro,,,,10.6019/CHEMBL4507261,CHEMBL4507261,Data for DCP probe A-192621,SGC Frankfurt,"SGC Frankfurt donated chemical probe project: A-192621 was donated by Abbvie. Website: https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/A-192621. Control: A-1806262. References: 1. Wu-Wong, J Ruth, Douglas B Dixon, William J Chiou, Brian K Sorensen, Gang Liu, H S Jae, Andrew Tasker, Thomas W von Geldern, Martin Winn, and Terry J Opgenorth. 2002. ‘Pharmacology of Endothelin Receptor Antagonists ABT-627, ABT-546, A-182086 and A-192621: In Vitro Studies’. Clinical Science (London, England: 1979) 103 Suppl 48:107S-111S. PMID: 12193066. 2. Wessale, Jerry L, Andrew L Adler, Eugene I Novosad, Samuel V Calzadilla, Brian D Dayton, Kennan C Marsh, Martin Winn, Hwan-Soo Jae, Thomas W von Geldern, Terry J Opgenorth, and J Ruth Wu-Wong. 2002. ‘Pharmacology of Endothelin Receptor Antagonists ABT-627, ABT-546, A-182086 and A-192621: Ex Vivo and in Vivo Studies’. Clinical Science (London, England: 1979) 103 Suppl 48:112S-117S. PMID: 12193067 .","InChI=1S/C33H38N2O6/c1-4-16-39-25-13-10-23(11-14-25)32-30(33(37)38)26(24-12-15-27-28(17-24)41-20-40-27)18-35(32)19-29(36)34-31-21(5-2)8-7-9-22(31)6-3/h7-15,17,26,30,32H,4-6,16,18-20H2,1-3H3,(H,34,36)(H,37,38)/t26-,30-,32+/m0/s1",0.31,-0.57,-11.6
MIVWTBCJCNWAEJ-UHFFFAOYSA-N,%,% Inhibition of Control Specific Binding (Mean n=2),,BAO_0000179,% Inhibition of Control Specific Binding (Mean n=2),AGONIST,115318,AR (h) Eurofins-Cerep binding assay,In vitro,,,,10.6019/CHEMBL4507310,CHEMBL4507310,Data for DCP probe A-1211212,SGC Frankfurt,"SGC Frankfurt donated chemical probe project: A-1211212 was donated by Abbvie. Website: https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/A-1211212. Control: A-1210227. References: 1. Leverson, Joel D, Darren C Phillips, Michael J Mitten, Erwin R Boghaert, Dolores Diaz, Stephen K Tahir, Lisa D Belmont, Paul Nimmer, Yu Xiao, Xiaoju Max Ma, Kym N Lowes, Peter Kovar, Jun Chen, Sha Jin, Morey Smith, John Xue, Haichao Zhang, Anatol Oleksijew, Terrance J Magoc, Kedar S Vaidya, Daniel H Albert, Jacqueline M Tarrant, Nghi La, Le Wang, Zhi-Fu Tao, Michael D Wendt, Deepak Sampath, Saul H Rosenberg, Chris Tse, David C S Huang, Wayne J Fairbrother, Steven W Elmore, and Andrew J Souers. 2015. ‘Exploiting Selective BCL-2 Family Inhibitors to Dissect Cell Survival Dependencies and Define Improved Strategies for Cancer Therapy’. Science Translational Medicine 7(279):279ra40. PMID: 25787766 (Secondary paper). 2. Weder, B., M. Mozaffari, L. Biedermann, C. Mamie, A. Moncsek, L. Wang, S. H. Clarke, G. Rogler, B. L. McRae, C. L. Graff, P. A. Ruiz, and M. Hausmann. 2018. ‘BCL-2 Levels Do Not Predict Azathioprine Treatment Response in Inflammatory Bowel Disease, but Inhibition Induces Lymphocyte Apoptosis and Ameliorates Colitis in Mice’. Clinical and Experimental Immunology 193(3):346–60. PMID: 29745420 (Secondary paper).","InChI=1S/C44H41ClF3N7O7S/c45-33-5-2-29(3-6-33)38-22-32(44(46,47)48)4-1-31(38)27-53-15-17-54(18-16-53)34-7-9-37(41(23-34)62-35-21-30-11-14-49-42(30)51-26-35)43(56)52-63(59,60)36-8-10-39(40(24-36)55(57)58)50-25-28-12-19-61-20-13-28/h1-11,14,21-24,26,28,50H,12-13,15-20,25,27H2,(H,49,51)(H,52,56)",0.07,-1.41,-0.7
SOYCFODXNRVBTI-UHFFFAOYSA-N,%,% Inhibition of Control Specific Binding (Mean n=2),,BAO_0000179,% Inhibition of Control Specific Binding (Mean n=2),AGONIST,115319,AR (h) Eurofins-Cerep binding assay,In vitro,,,,10.6019/CHEMBL4507311,CHEMBL4507311,Data for DCP probe A-1155463,SGC Frankfurt,"SGC Frankfurt donated chemical probe project: A-1155463 was donated by Abbvie. Website: https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/A-1155463. Control: A-1107969. References: 1. Tao, Zhi-Fu, Lisa Hasvold, Le Wang, Xilu Wang, Andrew M Petros, Chang H Park, Erwin R Boghaert, Nathaniel D Catron, Jun Chen, Peter M Colman, Peter E Czabotar, Kurt Deshayes, Wayne J Fairbrother, John A Flygare, Sarah G Hymowitz, Sha Jin, Russell A Judge, Michael F T Koehler, Peter J Kovar, Guillaume Lessene, Michael J Mitten, Chudi O Ndubaku, Paul Nimmer, Hans E Purkey, Anatol Oleksijew, Darren C Phillips, Brad E Sleebs, Brian J Smith, Morey L Smith, Stephen K Tahir, Keith G Watson, Yu Xiao, John Xue, Haichao Zhang, Kerry Zobel, Saul H Rosenberg, Chris Tse, Joel D Leverson, Steven W Elmore, and Andrew J Souers. 2014. ‘Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity’. ACS Medicinal Chemistry Letters 5(10):1088–93. PMID: 25313317. 2. Leverson, Joel D, Darren C Phillips, Michael J Mitten, Erwin R Boghaert, Dolores Diaz, Stephen K Tahir, Lisa D Belmont, Paul Nimmer, Yu Xiao, Xiaoju Max Ma, Kym N Lowes, Peter Kovar, Jun Chen, Sha Jin, Morey Smith, John Xue, Haichao Zhang, Anatol Oleksijew, Terrance J Magoc, Kedar S Vaidya, Daniel H Albert, Jacqueline M Tarrant, Nghi La, Le Wang, Zhi-Fu Tao, Michael D Wendt, Deepak Sampath, Saul H Rosenberg, Chris Tse, David C S Huang, Wayne J Fairbrother, Steven W Elmore, and Andrew J Souers. 2015. ‘Exploiting Selective BCL-2 Family Inhibitors to Dissect Cell Survival Dependencies and Define Improved Strategies for Cancer Therapy’. Science Translational Medicine 7(279):279ra40. PMID: 25787766. 3. Bulanova, Daria, Aleksandr Ianevski, Andrii Bugai, Yevhen Akimov, Suvi Kuivanen, Henrik Paavilainen, Laura Kakkola, Jatin Nandania, Laura Turunen, Tiina Ohman, Hanna Ala-Hongisto, Hanna M Pesonen, Marika S Kuisma, Anni Honkimaa, Emma L Walton, Valentyn Oksenych, Martina B Lorey, Dmitry Guschin, Jungmin Shim, Jinhee Kim, Thoa T Than, So Young Chang, Veijo Hukkanen, Evgeny Kulesskiy, Varpu S Marjomaki, Ilkka Julkunen, Tuula A Nyman, Sampsa Matikainen, Jani S Saarela, Famara Sane, Didier Hober, Gülsah Gabriel, Jef K De Brabander, Miika Martikainen, Marc P Windisch, Ji-Young Min, Roberto Bruzzone, Tero Aittokallio, Markus Vähä-Koskela, Olli Vapalahti, Arto Pulk, Vidya Velagapudi, and Denis E Kainov. 2017. ‘Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins’. Viruses 9(10). PMID: 28946654.","InChI=1S/C35H32FN5O4S2/c1-40(2)17-6-8-22-14-15-28(26(36)20-22)45-19-7-13-30-31(33(43)44)38-35(47-30)41-18-16-23-9-5-10-24(25(23)21-41)32(42)39-34-37-27-11-3-4-12-29(27)46-34/h3-5,9-12,14-15,20H,7,13,16-19,21H2,1-2H3,(H,43,44)(H,37,39,42)",0.13,-1.50,-1.8
